STRATA CRITICAL MEDICAL, INC. Legal Fees
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Legal Fees of $345.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2025-08-05
- STRATA CRITICAL MEDICAL, INC. legal fees for the quarter ending 2025-06-30 was $345.00K, a 148.20% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. legal fees for the quarter ending 2025-03-31 was $358.00K, a 191.06% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. legal fees for the quarter ending 2024-12-31 was $1.29M, a 2695.65% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. legal fees for the quarter ending 2024-09-30 was $165.00K, a 23.96% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. legal fees for fiscal 2024 was $1.71M, a 149.71% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. legal fees for fiscal 2023 was $686.00K.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|
| 2025-06-30 | $345.00K 10-Q · filed 2025-08-05 | $703.00K 10-Q · filed 2025-08-05 | $1.99M derived: sum of 3 quarters · filed 2025-08-05 | $2.15M derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | $358.00K 10-Q · filed 2025-05-12 | $1.64M derived: sum of 2 quarters · filed 2025-05-12 | $1.81M derived: sum of 3 quarters · filed 2025-05-12 | $1.95M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.45M derived: sum of 2 quarters · filed 2025-03-13 | $1.59M derived: sum of 3 quarters · filed 2025-08-05 | $1.71M 10-K · filed 2025-03-13 |
| 2024-09-30 | $165.00K 10-Q · filed 2024-11-12 | $304.00K derived: sum of 2 quarters · filed 2025-08-05 | $427.00K 10-Q · filed 2024-11-12 | $473.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-06-30 | $139.00K 10-Q · filed 2025-08-05 | $262.00K 10-Q · filed 2025-08-05 | $308.00K derived: sum of 3 quarters · filed 2025-08-05 | $525.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $123.00K 10-Q · filed 2025-05-12 | $169.00K derived: sum of 2 quarters · filed 2025-05-12 | $386.00K derived: sum of 3 quarters · filed 2025-05-12 | $386.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $263.00K derived: sum of 2 quarters · filed 2025-03-13 | $263.00K derived: sum of 3 quarters · filed 2025-03-13 | $686.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $217.00K 10-Q · filed 2024-11-12 | $217.00K derived: sum of 2 quarters · filed 2024-11-12 | $640.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $423.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $423.00K 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |